Veru Inc.
NASDAQ:VERUBiotechnology
+$0.13 today
- Market cap
- $50.72M
- Beta
- -1.13
- P/E (TTM)
- -4.8
- EPS (TTM)
- -$0.65
Volume 0.34M
Average 1.82M
VERU Gross Profit
Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.
Veru Inc.NASDAQ: VERU
Gross Profit · Q2 FY2026 · quarter ended Mar 2026
Gross profit remains negative
Q2 FY2026 gross profit was $0, compared with $0 a year earlier. Trailing-twelve-month gross profit was -$86.1K.
Context
- Gross profit increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly gross profit holds near $0 or moves back toward the trailing-twelve-month quarterly average of -$21.52K.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Profit history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- -100.0%
| Period | Period end | Gross Profit | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 0 | -100.0% |
| FY2024 | 2024-09-30 | 5.85M | -22.6% |
| FY2023 | 2023-09-30 | 7.57M | -75.3% |
| FY2022 | 2022-09-30 | 30.59M | -36.2% |
| FY2021 | 2021-09-30 | 47.93M | — |
Gross Profit vs competitors
How VERU compares with its peers on the latest reported figures
- VERU's LTM Mar 2026 gross profit of -$86.1K is the lowest of the 7 companies compared; the peer median is $464.97K.
- Its year-over-year change of -102.1% is the lowest of 4, against a peer median of -48.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Dec 2025 | $20.19M | -48.5% | — | 76.0% | |
| LTM Mar 2026 | $1.17M | +702.7% | — | 78.7% | |
| LTM Mar 2026 | $929.95K | -53.4% | — | 31.3% | |
| LTM Mar 2026 | $0 | — | — | — | |
| LTM Mar 2026 | $0 | — | — | — | |
| LTM Mar 2026 | $0 | — | — | — | |
| LTM Mar 2026 | -$86.1K | -102.1% | — | — | |
| Peer median (excluding VERU) | $464.97K | -48.5% | — | 76.0% | |
Competitors are the stored peer set for VERU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Revenue | 61.26M | 39.35M | 16.3M | 16.89M | 0 |
| Cost of Revenue | 13.33M | 8.76M | 8.73M | 11.03M | 0 |
| Gross Profit | 47.93M | 30.59M | 7.57M | 5.85M | 0 |
| Gross Margin | 78.2% | 77.7% | 46.4% | 34.7% | — |
| Research & Development | 32.69M | 70.65M | 51.2M | 12.81M | 15.59M |
| Selling, General & Admin | 20.67M | 43.17M | 48.06M | 31.18M | 19.94M |
| Operating Expenses | 53.36M | 113.81M | 101.35M | 42.77M | 24.75M |
| Depreciation & Amortization | 593.87K | 209.6K | 269.87K | 268.18K | 152.11K |
| EBITDA | 9.75M | (79.23M) | (89.98M) | (36.2M) | (35.38M) |
| EBITDA Margin | 15.9% | -201.3% | -552.1% | -214.4% | — |
| Operating Income | 12.97M | (83.22M) | (93.78M) | (36.92M) | (24.75M) |
| Operating Margin | 21.2% | -211.5% | -575.5% | -218.6% | — |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 4.89M | 4.37M | 2.43M | 607.47K | 0 |
| Other Income / Expenses | (8.71M) | (580.66K) | 1.11M | (160.93K) | 9.07M |
| Income Before Tax | 4.27M | (83.8M) | (92.67M) | (37.08M) | (15.68M) |
| Pre-Tax Margin | 7.0% | -212.9% | -568.6% | -219.6% | — |
| Income Tax Expense | (3.13M) | 236.4K | 480.21K | 725.1K | 0 |
| Net Income | 7.39M | (83.78M) | (93.15M) | (37.8M) | (22.73M) |
| Net Margin | 12.1% | -212.9% | -571.6% | -223.9% | — |
| EPS (Basic) | 0.97 | (10.49) | (10.96) | (2.80) | (1.07) |
| EPS (Diluted) | 0.88 | (10.49) | (10.96) | (2.80) | (1.07) |
| Weighted Avg Shares | 7.63M | 8.01M | 8.5M | 13.49M | 14.65M |
| Weighted Avg Shares (Diluted) | 8.38M | 8.01M | 8.5M | 13.49M | 14.65M |
Veru Inc.
NASDAQ:VERU
Intrinsic Alpha fair value
Locked
Current Price
$3.16
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.